Dr. Joshua Park is a Scientific Review Officer in the Clinical Sciences Section in NIA's Scientific Review Branch. Prior to joining NIA, Dr. Park was an assistant professor in the Department of Neurosciences and the Center for Diabetes and Endocrine Disorders at the University of Toledo College of Medicine. The focus of his research was on Alzheimer’s disease, pituitary biology, and bone disorders. He has developed potential therapeutic agents for neurodegenerative diseases (a food additive) and bone fractures (injectable bone device) that were PCT patented. This device was developed through NSF and Ohio I-Corps programs. In addition to his scholarly activities, he served in several roles including as director of the undergraduate research program and as a member of the Institutional Animal Care and Use Committee, Institutional Biosafety Committee, and medical school accreditation committee. He was a lecturer for neuropharmacology, neuroendocrinology, and medical embryology, and a mentor for graduate and undergraduate students.
Dr. Park holds a MS degree in Pharmacology, Microbiology, and Immunology from the Medical University of South Carolina and a PhD in Biochemistry and Molecular and Cellular Biology from Johns Hopkins University. Thereafter, he pursued postdoctoral training at the NICHD in neurosciences, endocrinology, and neuroendocrinology. He is a recipient of K and ARRA grants and other awards from NIH and other funding agencies.
Dr. Park has 24 publications including book chapters in the fields of Alzheimer’s disease, endocrine and neuroendocrine diseases, neurosciences, cancer biology, and cellular pharmacology. He has also served as reviewer for peer-reviewed papers in scientific journals including Science, Biological Psychiatry, etc., and for grant applications for the Alzheimer’s Association.